A Quarter Of New €300m VC Fund To Go Into Medtech
This article was originally published in Clinica
Executive Summary
European venture capital firm Sofinnova Partners will be investing about a quarter of its new €300m fund, Sofinnova Capital VIII, into medtech, while the remainder will go into biotech.